[IL2] Invited Lecture 2

[IL2-1] Improving efficacy and safety of AAV vectors for in vivo gene therapy

^○Hildegard Büning (Hannover Medical School)

1997-2003: Post-doctoral Fellow, Gene Center of the LMU Munich, Germany
2004-2015: Research Group Leader, Laboratory for AAV Vector Development, University of Cologne, Germany
Since 2015: Research Group Leader, Laboratory for Infection Biology & Gene Transfer, MHH, Germany
Since 2017: Deputy Director, Institute of Experimental Hematology, MHH, Germany